5.1% Surge in Osteoporosis Treatment Market Growth: Forecasted to Cross $17.84059018 Billion by 2029

 The Business Research Company’s report on the Osteoporosis Treatment Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.

 
 How have key drivers contributed to the rapid growth of the osteoporosis treatment market?
 The increasing prevalence and incidence of osteoporosis are expected to propel the growth of the osteoporosis treatment market going forward. Osteoporosis is a bone disease that manifests when bone strength and composition change or when bone mass and mineral density drop. Most osteoporosis drugs function by slowing down the rate at which your bones deteriorate. At the same time, hormone-based treatments such as estrogen can help maintain bone density, especially when taken immediately after menopause. For instance, in May 2022, according to Amgen, a US-based biopharmaceutical company, the annual number of fractures due to osteoporosis is expected to increase by 68% to 3.2 million by 2040. Furthermore, in April 2022, according to National Library of Medicine, a US-based national resource for health professionals, in 2022, around 549,000 new fragility fractures are reported annually in the UK, with one-third of these cases occurring in men. Due to the aging population, this number is projected to rise by 19.6% by 2030. Therefore, the increasing prevalence and incidence of osteoporosis are driving the growth of the osteoporosis treatment market.
 
 Access Your Free Sample of the Global Osteoporosis Treatment Market Report — Get Insights Now!
 https://www.thebusinessresearchcompany.com/sample.aspx?id=12166&type=smp
 
 How has the osteoporosis treatment market size evolved, and what are the latest forecasts for its expansion?
 The osteoporosis treatment market size has grown steadily in recent years. It will grow from $13.96 billion in 2024 to $14.62 billion in 2025 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to aging population demographics, hormone replacement therapies, calcium and vitamin d supplementation, increased diagnostic tools, integration of digital health solutions
 
 The osteoporosis treatment market size is expected to see strong growth in the next few years. It will grow to $17.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rise in sedentary lifestyles, rising prevalence of secondary osteoporosis, virtual bone fracture clinics, gene therapy for osteoporosis, increased focus on men’s bone health. Major trends in the forecast period include advancements in biologics, integration of artificial intelligence, blockchain in bone health records, integration of machine learning.
 
 Gain Exclusive Market Insights — Customize Your Research Report Today For Fast Delivery!
 https://www.thebusinessresearchcompany.com/customise?id=12166&type=smp
 
 Which major companies dominate the osteoporosis treatment market?
 Major companies operating in the osteoporosis treatment market include Pfizer Inc., F. Hoffmann La Roche Ltd., Merck and Co Inc., AbbVie Inc., Novartis AG, GlaxoSmithKline Pharmaceutical Ltd., Takeda Pharmaceutical Company, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Asahi Kasei Corporation, AstraZeneca Plc., Viatris Inc., Teva Pharmaceuticals Industries Ltd., Daiichi Sankyo Company Ltd, Dr. Reddy’s Laboratories, Gedeon Richter Plc., Celltrion Inc., Luye Pharma Group, Ligand Pharmaceuticals Incorporated, Radius Health Inc., Haoma Medica Ltd., EffRx Pharmaceuticals SA
 
 What trends will shape the future of the organic light emitting diode (oled) market?
 Major companies operating in the osteoporosis treatment market are focused on developing advanced injectable osteoporosis treatments to sustain their position in the market. Injectable osteoporosis treatments are medications given via injection to prevent bone loss and reduce fracture risk in individuals with osteoporosis. These options provide a direct method for improving bone density and strengthening skeletal health. For instance, in November 2023, Apotex Corp., a Canada-based pharmaceutical corporation, launched Teriparatide Injection. It is a pre-filled pen intended for single-patient use in treating osteoporosis. It contains a concentration of 250 mcg/mL and offers 28 daily doses of 20 mcg each per pen. This product seeks to enhance access to affordable treatment for around 10 million Americans suffering from osteoporosis. Its development underscores Apotex’s dedication to producing complex generic medications, ensuring that patients receive high-quality treatment.
 
 Which region dominates the osteoporosis treatment market, and what factors contribute to its leadership?
 North America was the largest region in the osteoporosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Order Your Report Now For Swift Delivery
 https://www.thebusinessresearchcompany.com/report/osteoporosis-treatment-global-market-report
 
 How is the osteoporosis treatment market segmented, and which segment holds the largest share?
 The osteoporosis treatment market covered in this report is segmented –
 
 1) By Drug Type: Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor
 2) By Route Of Administration: Oral, Injectable, Other Routes
 3) By Distribution Channel: Hospitals, Retail Pharmacies And Stores, Online Pharmacies
 
 Subsegments:
 1) By Bisphosphonates: Alendronate, Risedronate, Ibandronate, Zoledronic Acid
 2) By Calcitonin: Salmon Calcitonin, Synthetic Calcitonin Formulations
 3) By Hormone Therapy: Estrogen Replacement Therapy, Combination Hormone Therapy (Estrogen And Progesterone)
 4) By Selective Estrogen Receptor Modulators (SERMs), Raloxifene, Bazedoxifene
 5) By Parathyroid Hormone-Related Protein (PTHrP) Analog: PTH Analog (Teriparatide), Other PTHrP Analogues
 6) By Rank Ligand (RANKL) Inhibito: Denosumab
 
 Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
 https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12166
 
 How is the osteoporosis treatment market defined?
 Osteoporosis treatment refers to medical interventions aimed at managing and improving the condition of osteoporosis. Osteoporosis is a bone disease that appears when bone mass and mineral density decline or when the composition and strength of bones alter. The purpose of osteoporosis treatment is to halt bone deterioration, minimize fracture risk, and enhance overall bone health.
 
 About The Business Research Company:
 
 With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead. 
 
 Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
 
 Contact Us:
 
 The Business Research Company
 
 https://thebusinessresearchcompany.com/
 
 Europe: +44 207 1930 708
 
 Asia: +91 88972 63534
 
 Americas: +1 315 623 0293
 
 Email: info@tbrc.info
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company